P-CARE K40MX- triamcinolone acetonide, bupivacaine hcl, lidocaine hcl, sodium chloride, povidone iodine, isopropyl alcohol kit

Country: Stati Uniti

Lingwa: Ingliż

Sors: NLM (National Library of Medicine)

Ixtrih issa

Ingredjent attiv:

POVIDONE-IODINE (UNII: 85H0HZU99M) (IODINE - UNII:9679TC07X4)

Disponibbli minn:

RX PHARMA-PACK, INC.

INN (Isem Internazzjonali):

POVIDONE-IODINE

Kompożizzjoni:

IODINE 10 mg in 1 mL

Tip ta 'preskrizzjoni:

PRESCRIPTION DRUG

Indikazzjonijiet terapewtiċi:

Intramuscular Where oral therapy is not feasible, injectable corticosteroid therapy, including Kenalog-40 Injection and Kenalog-80 Injection (triamcinolone acetonide injectable suspension, USP) are indicated for intramuscular use as follows: Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. Dermatologic diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (Stevens-Johnson syndrome). Endocrine disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy, mineralocorticoid supplementation is of particular importance), congenital adrenal hyper

Sommarju tal-prodott:

Kenalog®- 40 Injection (triamcinolone acetonide injectable suspension, USP) is supplied in vials providing 40 mg triamcinolone acetonide per mL. Kenalog® -80 Injection (triamcinolone acetonide injectable suspension, USP) is supplied in vials providing 80 mg triamcinolone acetonide per mL. Bristol-Myers Squibb Company Princeton, NJ 08543 USA 1374114A0 Revised: April 2019 Sodium Chloride Injection, USP, 0.9%, preservative free, is available as follows: NDC 63323-186-04 2 mL fill, in a 3 mL Single-Dose vial NDC 63323-186-01 10 mL Single-Dose vial Preservative Free. Discard unused portion. Use only if solution is clear and seal intact. Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Fresenius Kabi Logo www.fresenius-kabi.com 45764E Revised: October 2018 Xylocaine® (lidocaine HCl Injection, USP) 0.5% (250 mg per 50 mL) (5 mg per mL) Xylocaine® -MPF (lidocaine HCl Injection, USP) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) with Epinephrine 1:100,000  1% (100 mg per 10 mL) (10 mg per mL) Xylocaine® (lidocaine HCl and epinephrine Injection, USP) with Epinephrine 1:200,000 NDC 63323-481-57 Unit of 25 Xylocaine® -MPF (lidocaine HCl and epinephrine Injection, USP) with Epinephrine 1:200,000 For single-dose vials and ampules: Discard unused portion. All solutions should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. All trademarks are the property of Fresenius Kabi USA, LLC. Fresenius Kabi Logo www.fresenius-kabi.com 4 5 1 1 7 5 F Revised: March 2019 These solutions are not for spinal anesthesia. Store at 20 to 25°C (68 to 77°F); excursions permitted between 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature.] MARCAINE― Solutions of MARCAINE that do not contain epinephrine may be autoclaved. Autoclave at 15-pound pressure, 121°C (250°F) for 15 minutes. MARCAINE with epinephrine 1:200,000 (as bitartrate)―Solutions of MARCAINE that contain epinephrine should not be autoclaved and should be protected from light. Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains a precipitate .  0 .25% with epinephrine 1:200,000 --- Contains 2.5 mg bupivacaine hydrochloride per mL. 0.5% with epinephrine 1:200,000 --- Contains 5 mg bupivacaine hydrochloride per mL. For single-dose vials: Discard unused portion. Distributed by Hospira, Inc., Lake Forest, IL 60045 USDA Revised: 11/2018

L-istatus ta 'awtorizzazzjoni:

New Drug Application

Karatteristiċi tal-prodott

                                P-CARE K40MX- TRIAMCINOLONE ACETONIDE, BUPIVACAINE HCL, LIDOCAINE HCL,
SODIUM CHLORIDE,
POVIDONE IODINE, ISOPROPYL ALCOHOL
RX PHARMA-PACK, INC.
----------
P-CARE K40MX
KENALOG-40 INJECTION - TRIAMCINOLONE ACETONIDE INJECTION, SUSPENSION
KENALOG -40 INJECTION
(TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION, USP)
E.R. SQUIBB & SONS, L.L.C.
NOT FOR USE IN NEONATES CONTAINS BENZYL ALCOHOL
FOR INTRAMUSCULAR OR INTRA-ARTICULAR USE ONLY
NOT FOR INTRAVENOUS, INTRADERMAL, INTRAOCULAR, EPIDURAL, OR
INTRATHECAL USE
DESCRIPTION
Kenalog
-40 Injection and Kenalog
-80 Injection (triamcinolone acetonide injectable suspension, USP)
are a synthetic glucocorticoid corticosteroid with anti-inflammatory
action. THESE FORMULATIONS
ARE SUITABLE FOR INTRAMUSCULAR AND INTRA-ARTICULAR USE ONLY. THESE
FORMULATIONS ARE NOT FOR INTRADERMAL INJECTION.
Kenalog
-40 Injection: Each mL of the sterile aqueous suspension provides 40
mg triamcinolone
acetonide, with 0.66% sodium chloride for isotonicity, 0.99% (w/v)
benzyl alcohol as a preservative,
0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80. Sodium
hydroxide or hydrochloric
acid may be present to adjust pH to 5.0 to 7.5. At the time of
manufacture, the air in the container is
replaced by nitrogen.
Kenalog
-80 Injection: Each mL of the sterile aqueous suspension provides 80
mg triamcinolone
acetonide, with 0.66% sodium chloride for isotonicity, 0.99% (w/v)
benzyl alcohol as a preservative,
0.63% carboxymethylcellulose sodium, and 0.04% polysorbate 80. Sodium
hydroxide or hydrochloric
acid may be present to adjust pH to 5.0 to 7.5. At the time of
manufacture, the air in the container is
replaced by nitrogen.
The chemical name for triamcinolone acetonide is
9-Fluoro-11β,16α,17,21-tetrahydroxypregna-1,4-
diene-3,20-dione cyclic 16,17-acetal with acetone. Its structural
formula is:
KENALOG -4 0 STRUCTURAL FORMULA
Triamcinolone acetonide occurs as a white to cream-colored,
crystalline powder having not more than a
slight odor and is practically insoluble in water and very soluble in
a
                                
                                Aqra d-dokument sħiħ
                                
                            

Fittex twissijiet relatati ma 'dan il-prodott